Mitigating Breast Cancer with Intratumoral In Situ pH-responsive Abemaciclib-loaded Novasome Hydrogel.
Findings underscore the clinical potential of the intratumoral IPANF hydrogel as a highly efficient, localized, and safe platform for advanced breast cancer treatment and validate the superior therapeutic efficacy of the hydrogel.